1-20 of 61
Juan Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle

Carys S. Johnson, Matthew Williams, Kendig Sham, Serena Belluschi, Wenjuan Ma, Xiaonan Wang, Winnie W. Y. Lau, Kerstin B. Kaufmann, Gabriela Krivdova, Emily F. Calderbank, Nicole Mende, Jessica McLeod, Giovanna Mantica, Juan Li, Charlotte Grey-Wilson, Michael Drakopoulos, Shaaezmeen Basheer, Shubhankar Sinha, Evangelia Diamanti, Christina Basford, Nicola K. Wilson, Steven J. Howe, John E. Dick, Berthold Göttgens, Anthony R. Green, Natalie Francis, Elisa Laurenti
Journal: Blood
Blood (2024) 144 (7): 729–741.
https://doi.org/10.1182/blood.2023021426
Published: 2024
Includes: Supplemental data
Journal Articles

First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Factor XI Monoclonal Antibody SHR-2004 in Healthy Subjects

Tingting Ma, Bei Cao, Zuyi Weng, Yanli Dong, Shimin An, Lei Huang, Yuanxun Yang, Yan Geng, Hui Lin, Yuqi Wang, Pinhao Xie, Kai Shen, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 3981.
https://doi.org/10.1182/blood-2023-173295
Published: 2023
Journal Articles

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

Li Chen, Hongming Zhu, Fangyi Dong, Yan Li, Qifa Liu, Yu Hu, Yicheng Zhang, Jie Jin, Jianda Hu, Ting Liu, Depei Wu, Jieping Chen, Yongrong Lai, Jianxiang Wang, Juan Li, Jianyong Li, Xin Du, Xin Wang, Mingzhen Yang, Jinsong Yan, Guifang Ouyang, Li Liu, Ming Hou, Xiaojun Huang, Wen Jin, Yongmei Zhu, Jian Li, Kankan Wang, Zhu Chen, Sai-Juan Chen, Junmin Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 2946.
https://doi.org/10.1182/blood-2023-184433
Published: 2023
Journal Articles

MASS-4 Is More Suitable Than MASS-3 for Prognostic Stratification in Transplant-Eligible Patients Withnewly Diagnosed Multiple Myeloma

Fan Yang, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4695.
https://doi.org/10.1182/blood-2023-173813
Published: 2023
Journal Articles

Early M-Protein Immune Reconstitution after Autologous Hematopoietic Stem Cell Transplantation Is a Good Prognostic Marker for Patients with High-Risk Cytogenetic Multiple Myeloma

Huihui Zhu, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6670.
https://doi.org/10.1182/blood-2023-173819
Published: 2023
Journal Articles

Obtaining M Protein Immune Reconstitution As Soon As Possible after Tandem Autologous Hematopoietic Stem Cell Transplantation Improves the Prognosis of Patients with Newly Diagnosis Multiple Myeloma

Huihui Zhu, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6622.
https://doi.org/10.1182/blood-2023-173823
Published: 2023
Journal Articles

One Case of Heavy Chain Deposition Disease Treated with Dara+KD Regimen and Literature Review

Meilan Chen, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6773.
https://doi.org/10.1182/blood-2023-173818
Published: 2023
Journal Articles

On-Demand Plerixafor Added to High-Dose Cyclophosphamide and Pegylated Recombinant Human Granulocyte Colony-Stimulating Factorin the Mobilization of Patients with Multiple Myeloma: High Effectiveness and Affordable Cost

Liqiong Hou, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6669.
https://doi.org/10.1182/blood-2023-173781
Published: 2023
Journal Articles

The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment

Ming-Yue Fei, Yong Wang, Bin-He Chang, Kai Xue, Fangyi Dong, Dan Huang, Xi-Ya Li, Zi-Juan Li, Cheng-Long Hu, Ping Liu, Ji-Chuan Wu, Peng-Cheng Yu, Ming-Hua Hong, Shu-Bei Chen, Chun-Hui Xu, Bing-Yi Chen, Yi-Lun Jiang, Na Liu, Chong Zhao, Jia-Cheng Jin, Dan Hou, Xin-Chi Chen, Yi-Yi Ren, Chu-Han Deng, Jia-Ying Zhang, Li-juan Zong, Rou-Jia Wang, Fei-Fei Gao, Hui Liu, Qun-Ling Zhang, Ling-Yun Wu, Jinsong Yan, Shuhong Shen, Chun-Kang Chang, Xiao-Jian Sun, Lan Wang
Journal: Blood
Blood (2023) 142 (10): 903–917.
https://doi.org/10.1182/blood.2022019537
Published: 2023
Includes: Supplemental data
Journal Articles

Bortezomib-Decp Alternating with Daratumumab-Vpd Plus Stem Cell Transplantation, Followed By Maintenance with VP in Ultra-High Risk (UHiR) Newly Diagnosed Multiple Myeloma (NDMM) and Primary Plasma Cell Leukemia (pPCL): A Multicenter, Prospective Phase 2 Pilot Trial (DRAGON CATCHER TRIAL)

Jin Lu, Yang Liu, Jian Hou, Juan Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 10189–10190.
https://doi.org/10.1182/blood-2022-164563
Published: 2022
Journal Articles

Characteristics of 6 Cases of Overlapping Plasma Cell Disorders

Beihui Huang, Juan Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12537.
https://doi.org/10.1182/blood-2022-158745
Published: 2022
Journal Articles

Cytogenetic Evolution and Its Effect on Prognosis in Newly Diagnosed and Relapsed MM Patients

Yanjuan Li, Beihui Huang, Xiaozhe Li, Lifen Kuang, Meilan Chen, Junru Liu, Juan Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 12527.
https://doi.org/10.1182/blood-2022-157389
Published: 2022
Journal Articles

STAT1 is essential for HSC function and maintains MHCII hi stem cells that resist myeloablation and neoplastic expansion

Juan Li, Matthew J. Williams, Hyun Jung Park, Hugo P. Bastos, Xiaonan Wang, Daniel Prins, Nicola K. Wilson, Carys Johnson, Kendig Sham, Michelle Wantoch, Sam Watcham, Sarah J. Kinston, Dean C. Pask, Tina L. Hamilton, Rachel Sneade, Amie K. Waller, Cedric Ghevaert, George S. Vassiliou, Elisa Laurenti, David G. Kent, Berthold Göttgens, Anthony R. Green
Journal: Blood
Blood (2022) 140 (14): 1592–1606.
https://doi.org/10.1182/blood.2021014009
Published: 2022
Includes: Supplemental data
Journal Articles

A Prospective Clinical Study of the Efficacy and Adverse Reactions of Azacitidine Combined with IA Regimen As the Induction Treatment of Newly Diagnosed AML

Lifen Kuang, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4408.
https://doi.org/10.1182/blood-2021-145026
Published: 2021
Journal Articles

Sustained MRD Negativity Might Predict Successful Maintenance Discontinuation in Patients with Transplant-Eligible NDMM

Jingli Gu, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4747.
https://doi.org/10.1182/blood-2021-144435
Published: 2021
Journal Articles

The Analysis of Risk for Solitary Bone Plasmacytoma Rapidly Progressing to Multiple Myeloma

Meilan Chen, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4750.
https://doi.org/10.1182/blood-2021-145024
Published: 2021
Journal Articles

A Novel Risk Scoring System to Predict Survival in Soft Tissue-Related Extramedullary Multiple Myeloma

Beihui Huang, Qing Wang, Wuping Li, Ying Zhao, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4749.
https://doi.org/10.1182/blood-2021-144837
Published: 2021
Journal Articles

Efficacy and Safety of Decitabine Combined with IA Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Lifen Kuang, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 2341.
https://doi.org/10.1182/blood-2021-145027
Published: 2021
Journal Articles

The Prognostic Significance of the Stage of Reaching MRD-Negative for Patients with Multiple Myeloma Received ASCT

Qian Sun, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 3945.
https://doi.org/10.1182/blood-2021-145017
Published: 2021
Journal Articles

Prognostic Value of Flowcytometric Minimal Residual Disease Combined with PET/CT at Multiple Time Points before and after Autologous Stem Cell Transplantation in Multiple Myeloma

Jingli Gu, Juan Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 1838.
https://doi.org/10.1182/blood-2021-145018
Published: 2021